Clinical Trial: ADAMTS,Proteoglycan and Oxidant / Antioxidant Enzyme Levels of Placenta Previa Totalis (Accreta, Increta, Percreta).
Study Status: Completed
Recruit Status: Unknown status
Study Type: Observational [Patient Registry]
Official Title: ADAMTS, Proteoglycan and Oxidant / Antioxidant Enzyme Levels of Placenta Previa Totalis(Accreta, Increta, Percreta)
Brief Summary: Placenta previa totalis (accreta, increta, percreta); ADAMTS and proteoglycans and the oxidant / antioxidant enzyme levels.
Detailed Summary: Placenta previa totalis (accreta, increta, percreta) of pregnant women in the maternal serum, fetal membranes (placenta) and hysterectomy of women with myometrial strips measured the ADAMTS and proteoglycans expression levels, and the oxidant / antioxidant enzyme levels.
Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital
Current Primary Outcome: ADAMTS,Proteoglycan and Oxidant / Antioxidant Enzyme Levels of maternal serum in patients with the diagnosis of Placenta Previa (Accreta, increta, percreta) [ Time Frame: Up to 6 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- ADAMTS,Proteoglycan and Oxidant / Antioxidant Enzyme Levels of myometrial samples in patients with the diagnosis of Placenta Previa (Accreta, increta, percreta) [ Time Frame: Up to 6 months ]
- ADAMTS,Proteoglycan and Oxidant / Antioxidant Enzyme Levels of Fetal Membranes in patients with the diagnosis of Placenta Previa (Accreta, increta, percreta) [ Time Frame: Up to 6 months ]
- placenta previa totalis in the development, progression and in exacerbating; ADAMTS and proteoglycans, to determine the relationship of changes in expression. [ Time Frame: Up to 2 years ]
Original Secondary Outcome: Same as current
Information By: Zekai Tahir Burak Women's Health Research and Education Hospital
Dates:
Date Received: August 22, 2014
Date Started: August 2013
Date Completion: October 2015
Last Updated: October 16, 2014
Last Verified: October 2014
